Literature DB >> 1582684

Influence of antibiotics on IgA and IgG response and persistence of Yersinia enterocolitica in patients with Yersinia-associated spondylarthropathy.

J A Hoogkamp-Korstanje1, J de Koning, J Heesemann, J J Festen, P M Houtman, P L van Oyen.   

Abstract

The IgA and IgG antibody response to plasmid-encoded outer membrane proteins was studied in 59 patients with yersinia-associated spondylarthropathy during 15 months of follow-up. Initially, all patients had specific IgA and IgG antibodies to the 36 and 46 kDa and 30% also to the 26 and 58 kDa released proteins, which correlated with the finding of virulent Yersinia bacilli in intestinal biopsies. IgA disappeared in 69% of untreated patients after nine months and persisted in 31% after one year. IgA disappeared within three to six months in 81% of the patients treated with antibiotics for four to six weeks and persisted in 6% after one year (p less than 0.002). IgG antibodies to the 36 and 46 kDa outer membrane proteins persisted in 80% of all patients. Disappearance of IgA was coupled with disappearance of yersinia from intestinal biopsies.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1582684     DOI: 10.1007/bf01711062

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  17 in total

1.  Yersinia in intestinal biopsy specimens from patients with seronegative spondyloarthropathy: correlation with specific serum IgA antibodies.

Authors:  J de Koning; J Heesemann; J A Hoogkamp-Korstanje; J J Festen; P M Houtman; P L van Oijen
Journal:  J Infect Dis       Date:  1989-01       Impact factor: 5.226

2.  Analysis of the class-specific immune response to Yersinia enterocolitica virulence-associated antigens in oro-gastrically infected rabbits.

Authors:  J Heesemann; J Schröder; M Ulrich
Journal:  Microb Pathog       Date:  1988-12       Impact factor: 3.738

3.  Specificity of IgA class anti-yersinia antibodies in yersinia arthritis.

Authors:  K Granfors; T H Ståhlberg; O Isomäki; A Toivanen
Journal:  Scand J Rheumatol Suppl       Date:  1987

4.  Antibiotics in Yersinia enterocolitica infections.

Authors:  J A Hoogkamp-Korstanje
Journal:  J Antimicrob Chemother       Date:  1987-07       Impact factor: 5.790

5.  Incidence of human infection with Yersinia enterocolitica serotypes O3, O8, and O9 and the use of indirect immunofluorescence in diagnosis.

Authors:  J A Hoogkamp-Korstanje; J de Koning; J P Samsom
Journal:  J Infect Dis       Date:  1986-01       Impact factor: 5.226

Review 6.  Reiter's syndrome and reactive arthritis in perspective.

Authors:  A Keat
Journal:  N Engl J Med       Date:  1983-12-29       Impact factor: 91.245

7.  A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots.

Authors:  M S Blake; K H Johnston; G J Russell-Jones; E C Gotschlich
Journal:  Anal Biochem       Date:  1984-01       Impact factor: 3.365

8.  HLA-B27 related arthritis and bowel inflammation. Part 1. Sulfasalazine (salazopyrin) in HLA-B27 related reactive arthritis.

Authors:  H Mielants; E M Veys
Journal:  J Rheumatol       Date:  1985-04       Impact factor: 4.666

9.  Plasmids of human strains of Yersinia enterocolitica: molecular relatedness and possible importance for pathogenesis.

Authors:  J Heesemann; C Keller; R Morawa; N Schmidt; H J Siemens; R Laufs
Journal:  J Infect Dis       Date:  1983-01       Impact factor: 5.226

10.  Association of persisting IgA response with yersinia triggered reactive arthritis: a study on 104 patients.

Authors:  A Toivanen; R Lahesmaa-Rantala; R Vuento; K Granfors
Journal:  Ann Rheum Dis       Date:  1987-12       Impact factor: 19.103

View more
  6 in total

Review 1.  Bacteria-Triggered reactive arthritis: implications for antibacterial treatment.

Authors:  A Toivanen
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  Current evidence for human yersiniosis in Ireland.

Authors:  T Ringwood; B P Murphy; N Drummond; J F Buckley; A P Coveney; H P Redmond; J P Power; S Fanning; M B Prentice
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-06-03       Impact factor: 3.267

Review 3.  Chlamydia screening: which sample for which technique?

Authors:  A Stary
Journal:  Genitourin Med       Date:  1997-04

4.  PCR-based characterization of Yersinia enterocolitica: comparison with biotyping and serotyping.

Authors:  P T Odinot; J F Meis; P J Van den Hurk; J A Hoogkamp-Korstanje; W J Melchers
Journal:  Epidemiol Infect       Date:  1995-10       Impact factor: 2.451

5.  Increased prevalence of antibodies to enteropathogenic Yersinia enterocolitica virulence proteins in relatives of patients with autoimmune thyroid disease.

Authors:  T G A Strieder; B E Wenzel; M F Prummel; J G P Tijssen; W M Wiersinga
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

Review 6.  Terminal Ileitis due to Yersinia Infection: An Underdiagnosed Situation.

Authors:  John K Triantafillidis; Thomas Thomaidis; Apostolos Papalois
Journal:  Biomed Res Int       Date:  2020-05-23       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.